JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SUGARMAN, S. R.
Right arrow Articles by MOHAMMED, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SUGARMAN, S. R.
Right arrow Articles by MOHAMMED, S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 162, Issue 1, 115-120, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF METHYLDOPA ON CHRONOTROPIC RESPONSES TO CARDIOACCELERATOR NERVE STIMULATION IN DOGS

SIGMUND R. SUGARMAN 1, HARRY S. MARGOLIUS 1, THOMAS E. GAFFNEY 1, and SHAKIL MOHAMMED 1

1 Division of Clinical Pharmacology, Departments of Pharmacology and Internal Medicine, University of Cincinnati, College of Medicine, Cincinnati, Ohio

Indirect evidence in man suggests that methyldopa impairs reflex sympathetic cardiovascular responses; however, diverse effects of this drug have been reported on the responses to direct sympathetic stimulation in animals. The effects of a single injection and chronic treatment with methyldopa on the frequency-response characteristics of the dog heart cardioaccelerator nerve preparation and on the chronotropic effects of exogenous norepinephrine and methyl-norepinephrine were systematically studied. Acute methyldopa, 100 mg/kg of base, clearly reduced chronotropic responses to cardioaccelerator nerve stimulation after 90 min at a time when the chronotropic effects of norepinephrine and methyl-norepinephrine were identical and similar in magnitude to those in control dogs. Chronic methyldopa, 100 mg/kg/day for 4 to 5 days, did not affect the chronotropic responses to direct sympathetic stimulation; however, the dose-chronotropic response curves of both methyl-norepinephrine and norepinephrine were shifted equally and significantly to the left. These observations viewed collectively suggest the possibility that a reduced amount of transmitter, natural or false, may be released after acute or chronic treatment with methyldopa. Subnormal release of transmitter may also be partially responsible for the hypotensive effect of methyldopa in man, and the supersensitivity to methyl-norepinephrine and norepinephrine after chronic treatment with methyldopa may explain the tolerance to the antihypertensive effect of methyldopa seen in man.

Submitted on March 11, 1967
Accepted on March 13, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.